USFDA Oral Solid Dosages

Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products.  USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets.  Many products are made in USA products in FDA approved facilities.

Lodaat has an extensive portfolio of Biosimilars, Biologics, and High Value Molecules including ADCs, MABs and other large molecules.  We are looking for reputable global partners who want to expand their product line and in-license for their territory.

LODAAT's Oral Solid Dosages are EU-GMP facility approved and are available in innovations such as ODT, Sachets, and Extended Release.  Our facilities handle all testing, production and full packaging capabilities.

LODAAT produces the best quality USA made Vitamins, Herbal supplements, Minerals and OTC products.  Our finished formulations are available in Tablets and Capsules.  We have 3 US facilities producing Private Label and Branded goods in Bottles and Blister packaging.  Best selling products inc...

Lodaat's Oncology Colombian INVIMA approved injectables with CTD dossier

In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conference.  

This video provides an Introduction to the LODAAT team, product categories, facilities, research and innovation.

At CPHI Barcelona (24–26 October, 2023) we took the time to catch up with one of our speakers, Rajiv Khatau who gave a presentation on: The Microbiome Boom - Unlocking Potential Through Listening to the Gut and was a panellist on: Why Building a Collaborative Network is Essential for Rare Disease Therapies. 

CITIZEN DOCTOR: PERSONALIZED MEDICINEFOR INGREDIENT INDUSTRY- How Personalized medicine can be implemented